NCT05199532 Eosinophilic Gastrointestinal Disorders Registry
| NCT ID | NCT05199532 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ann & Robert H Lurie Children's Hospital of Chicago |
| Condition | Eosinophilic Esophagitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-12-18 |
| Primary Completion | 2030-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2020-12-18 with a primary completion date of 2030-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to learn more about Eosinophilic Gastrointestinal Disorders (EGIDs). With this registry we hope to find out more about the symptoms that patients have during their treatment, the quality of life they have with the diagnosis, what the disease looks like throughout the different treatment methods, and if there is a connection between EGIDs and connective tissue disorders. The goal of this study is to be able to better understand EGIDs and use information gained from all the information collected on this study for more precise treatments in the future. We want to create a large collection of samples, called a biorepository, to learn the most about EGIDs as possible. When the samples are collected, which will occur at procedures directed by your child's doctor as part of their standard of care, they will be stored for an unlimited amount of time to perform experiments on these samples and to gather information about EGIDs
Eligibility Criteria
Inclusion Criteria: * Patients with an established diagnosis of an EGID, based on pathology findings from an endoscopy or colonoscopy with biopsies. * Patients suspected of having an EGID and undergoing endoscopic evaluation for further assessment Exclusion Criteria: * Patients who do not consent to participate
Contact & Investigator
Joshua B Wechsler, MD
PRINCIPAL INVESTIGATOR
Ann & Robert H Lurie Children's Hospital of Chicago
Frequently Asked Questions
Who can join the NCT05199532 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 25 Years, studying Eosinophilic Esophagitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05199532 currently recruiting?
Yes, NCT05199532 is actively recruiting participants. Contact the research team at aanthony@luriechildrens.org for enrollment information.
Where is the NCT05199532 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05199532 clinical trial?
NCT05199532 is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. The principal investigator is Joshua B Wechsler, MD at Ann & Robert H Lurie Children's Hospital of Chicago. The trial plans to enroll 500 participants.